Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Fire06on Feb 05, 2019 6:09am
392 Views
Post# 29318997

Big Pharma was in Leamington - Company named Amgen

Big Pharma was in Leamington - Company named AmgenI live near Aphria greenhouses (Aphria and Aphria Diamond). I was told by a few people that Amgen top executives, a massive Pharmaceutical company has visited Aphria headquarters a few times in Jan 2019. Take it for what’s its worth. I’m just trying to find out why this stock is running the way it is. I’m not saying this is 100% a partner or anything but this is what I’ve been told. 
Bullboard Posts